LYRIX | VEVYX | LYRIX / VEVYX | |
Total Expense Ratio | 0.99 | 0.66 | 150% |
Annual Report Gross Expense Ratio | 1.02 | 0.66 | 155% |
Fund Existence | 12 years | 12 years | - |
Gain YTD | 1.550 | -4.089 | -38% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 1000000 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 990M | 17B | 6% |
Annual Yield % from dividends | 0.21 | 1.15 | 18% |
Returns for 1 year | 8.48 | -9.20 | -92% |
Returns for 3 years | 32.39 | -2.22 | -1,461% |
Returns for 5 years | 121.67 | 46.07 | 264% |
Returns for 10 years | 64.32 | 40.43 | 159% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EQRR | 56.81 | 0.49 | +0.87% |
ProShares Equities for Rising Rates ETF | |||
IGE | 42.25 | 0.32 | +0.76% |
iShares North American Natural Res ETF | |||
FLRG | 33.51 | 0.07 | +0.21% |
Fidelity U.S. Multifactor ETF | |||
IYR | 93.74 | -0.41 | -0.44% |
iShares US Real Estate ETF | |||
RXL | 40.64 | -0.76 | -1.84% |
ProShares Ultra Health Care |